slides · global inventory
Problem Statement Canvas
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,665
Current window 2,011-2,040
Pages 89
Rows per page 30
Tool
2,011-2,040 of 2,665
29
The slide uses a grid of metrics to define the addressable market and the clinical problem (progression after 1L).BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations Beat · Market Sizing1 hit
11
The slide uses a numbered list format to categorize the problems.Blackwells Capital | Activist Presentation Deck | 101 slides · Blackwells Capital
Activist deck Activist investor 1 hit
68
Uses a numbered list format to categorize specific organizational and strategic failures.Blackwells Capital | Activist Presentation Deck | 101 slides · Blackwells Capital
Activist deck Activist investor 1 hit
69
Uses an org-chart style diagram to highlight the lack of a unified technology leader.Blackwells Capital | Activist Presentation Deck | 101 slides · Blackwells Capital
Activist deck Activist investor 1 hit
53
Uses a three-pillar structure to categorize performance failures.Blackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
65
Blackwells Capital | Activist Presentation Deck | 115 slidesBlackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
03
Uses a numbered list format to categorize specific organizational failures.Blackwells Capital | Activist Presentation Deck | 22 slides · Blackwells Capital
Activist deck Activist investor Beat · Problem1 hit
28
The slide uses a specific customer case study (Pattison Food Group) to frame a problem solvable by D-Wave's quantum optimization.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
30
The slide maps business rules for workforce management to mathematical optimization equations.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
61
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
62
Includes a definition of NP complexity and practical applications of TSP.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
84
The diagram uses a funnel metaphor to represent the synthesis of complex problems into specific project outcomes.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
88
The slide uses a network optimization problem as a use case for D-Wave's quantum computing capabilities.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
10
The slide uses a biological diagram to explain the 'problem' of immune evasion in cancer therapy.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
Uses a visual comparison framework to illustrate the 'Goldilocks' problem of cytokine inhibition (too narrow vs. too broad).Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Problem1 hit
30
Uses a clear contrast between patient count and available treatments to frame the market opportunity.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
16
Includes a Kaplan-Meier survival curve comparing existing standard-of-care options.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
24
The chart is a Kaplan-Meier survival curve comparing a control arm to an experimental arm (EC).Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
29
The slide uses a stacked bar chart to show mutation incidence and a comparison table to highlight clinical trial failures in GBM compared to other indications.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
20
Uses information theory to explain why 20 binary questions can narrow down a search space of 600,000 items.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
61
The diagram illustrates the interaction network of LSD1 with various suppressors and activators.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
74
The heatmap displays AUC values for 16 patient samples across 3 treatments. Source: Okumura et al. ESMO, 2023.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
07
The slide uses a hub-and-spoke diagram to centralize the problem of neurotoxicity.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
10
The slide uses a visual timeline/process flow to show disease progression.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a 'media montage' approach to establish urgency and external validation of the problem.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
14
The slide highlights both the clinical urgency (toxicity, resistance) and the commercial potential (orphan disease status).Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
14
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Loop · Cost Of Inaction1 hit
05
Uses a before-after-bridge style framing to connect pain points to product benefits.MaxCyte | Investor Presentation Deck | 21 slides · MaxCyte
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Includes a personal testimonial/case study image of a patient (Shay) to humanize the disease.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
03
The slide uses a combination of metrics and a growth chart to frame the market opportunity and the severity of the problem.Talkspace | Investor Conference Presentation Deck | 13 slides · Talkspace
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit